This inventor holds 1 USPTO granted patent. Top assignee: Biongene Co., Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Hyung-Moo Jung: Innovator in Teicoplanin Production
Introduction
Hyung-Moo Jung is a prominent inventor based in Seoul, South Korea. He is known for his significant contributions to the field of biotechnology, particularly in the production of teicoplanin, an important antibiotic.
Latest Patents
Hyung-Moo Jung holds a patent for a process for the production of teicoplanin. This invention provides a newly isolated mutant culture of BNG 2315, which is capable of producing teicoplanin with more than 60 times the productivity compared to previously reported strains, such as nov. sp. ATCC 31121. The patent also outlines a fermentation process for producing teicoplanin under aerobic conditions using the mutant strain BNG 2315 in a culture medium that includes carbon sources, nitrogen sources, and mineral salts.
Career Highlights
Hyung-Moo Jung is associated with Biongene Co., Ltd., where he continues to advance research in biotechnological applications. His work has been instrumental in enhancing the efficiency of antibiotic production, which is crucial for medical applications.
Collaborations
He has collaborated with notable colleagues, including Soo-Ryun Cheong and Sang-Young Kim, to further his research and development efforts in the field.
Conclusion
Hyung-Moo Jung's innovative work in the production of teicoplanin showcases his commitment to advancing biotechnology. His contributions are vital for improving antibiotic production processes, which can have a significant impact on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile